Serum MMP-3 as a predictive factor for joint destruction in patients with rheumatoid arthritis who have achieved remission or low disease activity and the clinically relevant cut-off value for the structural remission
Released on J-STAGE: March 31, 2026 |
Volume 5
Issue 1
Pages 34-45
Hiroe Konishi, Mai Morimoto, Kosaku Murakami, Akira Onishi, Takayuki Fujii, Koichi Murata, Masao Tanaka, Akio Morinobu, Masayoshi Nakano, Masahiro Koshiba